These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 22810587)
1. APJ acts as a dual receptor in cardiac hypertrophy. Scimia MC; Hurtado C; Ray S; Metzler S; Wei K; Wang J; Woods CE; Purcell NH; Catalucci D; Akasaka T; Bueno OF; Vlasuk GP; Kaliman P; Bodmer R; Smith LH; Ashley E; Mercola M; Brown JH; Ruiz-Lozano P Nature; 2012 Aug; 488(7411):394-8. PubMed ID: 22810587 [TBL] [Abstract][Full Text] [Related]
2. Apelin and APJ orchestrate complex tissue-specific control of cardiomyocyte hypertrophy and contractility in the hypertrophy-heart failure transition. Parikh VN; Liu J; Shang C; Woods C; Chang AC; Zhao M; Charo DN; Grunwald Z; Huang Y; Seo K; Tsao PS; Bernstein D; Ruiz-Lozano P; Quertermous T; Ashley EA Am J Physiol Heart Circ Physiol; 2018 Aug; 315(2):H348-H356. PubMed ID: 29775410 [TBL] [Abstract][Full Text] [Related]
3. Gαi-biased apelin analog protects against isoproterenol-induced myocardial dysfunction in rats. Coquerel D; Delile E; Dumont L; Chagnon F; Murza A; Sainsily X; Salvail D; Sarret P; Marsault E; Auger-Messier M; Lesur O Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1646-H1656. PubMed ID: 33635165 [TBL] [Abstract][Full Text] [Related]
4. Endogenous regulation of cardiovascular function by apelin-APJ. Charo DN; Ho M; Fajardo G; Kawana M; Kundu RK; Sheikh AY; Finsterbach TP; Leeper NJ; Ernst KV; Chen MM; Ho YD; Chun HJ; Bernstein D; Ashley EA; Quertermous T Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1904-13. PubMed ID: 19767528 [TBL] [Abstract][Full Text] [Related]
5. Possible involvement of downregulation of the apelin-APJ system in doxorubicin-induced cardiotoxicity. Hamada J; Baasanjav A; Ono N; Murata K; Kako K; Ishida J; Fukamizu A Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H931-41. PubMed ID: 25681427 [TBL] [Abstract][Full Text] [Related]
6. The mechanosensitive APJ internalization via clathrin-mediated endocytosis: A new molecular mechanism of cardiac hypertrophy. He L; Chen L; Li L Med Hypotheses; 2016 May; 90():6-10. PubMed ID: 27063076 [TBL] [Abstract][Full Text] [Related]
7. Apelin/APJ system: A bifunctional target for cardiac hypertrophy. Lu L; Wu D; Li L; Chen L Int J Cardiol; 2017 Mar; 230():164-170. PubMed ID: 27979574 [TBL] [Abstract][Full Text] [Related]
8. Caveolin-1-Autophagy Pathway Mediated Cardiomyocyte Hypertrophy Induced by Apelin-13. Wu D; Xie F; Xiao L; Feng F; Huang S; He L; Liu M; Zhou Q; Li L; Chen L DNA Cell Biol; 2017 Aug; 36(8):611-618. PubMed ID: 28537760 [TBL] [Abstract][Full Text] [Related]
9. Apelin ameliorates TNF-α-induced reduction of glycogen synthesis in the hepatocytes through G protein-coupled receptor APJ. Chu J; Zhang H; Huang X; Lin Y; Shen T; Chen B; Man Y; Wang S; Li J PLoS One; 2013; 8(2):e57231. PubMed ID: 23437347 [TBL] [Abstract][Full Text] [Related]
10. Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development. Kang Y; Kim J; Anderson JP; Wu J; Gleim SR; Kundu RK; McLean DL; Kim JD; Park H; Jin SW; Hwa J; Quertermous T; Chun HJ Circ Res; 2013 Jun; 113(1):22-31. PubMed ID: 23603510 [TBL] [Abstract][Full Text] [Related]
11. Lactation Is a Risk Factor of Postpartum Heart Failure in Mice with Cardiomyocyte-specific Apelin Receptor (APJ) Overexpression. Murata K; Ishida J; Ishimaru T; Mizukami H; Hamada J; Saito C; Fukamizu A J Biol Chem; 2016 May; 291(21):11241-51. PubMed ID: 27033703 [TBL] [Abstract][Full Text] [Related]
12. Apelin-36 Modulates Blood Glucose and Body Weight Independently of Canonical APJ Receptor Signaling. Galon-Tilleman H; Yang H; Bednarek MA; Spurlock SM; Paavola KJ; Ko B; To C; Luo J; Tian H; Jermutus L; Grimsby J; Rondinone CM; Konkar A; Kaplan DD J Biol Chem; 2017 Feb; 292(5):1925-1933. PubMed ID: 27994053 [TBL] [Abstract][Full Text] [Related]
13. In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart Failure. Gargalovic P; Wong P; Onorato J; Finlay H; Wang T; Yan M; Crain E; St-Onge S; Héroux M; Bouvier M; Xu C; Chen XQ; Generaux C; Lawrence M; Wexler R; Gordon D Circ Heart Fail; 2021 Mar; 14(3):e007351. PubMed ID: 33663236 [TBL] [Abstract][Full Text] [Related]
14. Apelin-13/APJ induces cardiomyocyte hypertrophy by activating the Pannexin-1/P2X7 axis and FAM134B-dependent reticulophagy. Yang Y; Zhang K; Huang S; Chen W; Mao H; Ouyang X; Chen L; Li L J Cell Physiol; 2022 Apr; 237(4):2230-2248. PubMed ID: 35128666 [TBL] [Abstract][Full Text] [Related]
15. In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure. Sheikh AY; Chun HJ; Glassford AJ; Kundu RK; Kutschka I; Ardigo D; Hendry SL; Wagner RA; Chen MM; Ali ZA; Yue P; Huynh DT; Connolly AJ; Pelletier MP; Tsao PS; Robbins RC; Quertermous T Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H88-98. PubMed ID: 17906101 [TBL] [Abstract][Full Text] [Related]
16. The microRNA-204-5p inhibits APJ signalling and confers resistance to cardiac hypertrophy and dysfunction. Gaddam RR; Kim YR; Jacobs JS; Yoon JY; Li Q; Cai A; Shankaiahgari H; London B; Irani K; Vikram A Clin Transl Med; 2022 Jan; 12(1):e693. PubMed ID: 35060347 [TBL] [Abstract][Full Text] [Related]
17. Apelin/APJ signaling is a critical regulator of statin effects in vascular endothelial cells--brief report. McLean DL; Kim J; Kang Y; Shi H; Atkins GB; Jain MK; Chun HJ Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2640-3. PubMed ID: 22995518 [TBL] [Abstract][Full Text] [Related]
18. Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling. Deng C; Chen H; Yang N; Feng Y; Hsueh AJ J Biol Chem; 2015 Jul; 290(30):18261-8. PubMed ID: 25995451 [TBL] [Abstract][Full Text] [Related]
19. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage. Sato T; Sato C; Kadowaki A; Watanabe H; Ho L; Ishida J; Yamaguchi T; Kimura A; Fukamizu A; Penninger JM; Reversade B; Ito H; Imai Y; Kuba K Cardiovasc Res; 2017 Jun; 113(7):760-769. PubMed ID: 28371822 [TBL] [Abstract][Full Text] [Related]